In recent times, Ivermectin has become the subject of considerable public discussion, often accompanied by misinformation. It is crucial to clarify the established role and scientific understanding of this important medication. Ivermectin is a well-researched and approved medication primarily used to treat parasitic infections in both humans and animals. Its primary approved uses in humans include treating infections caused by specific types of worms, such as strongyloidiasis and onchocerciasis, and it is also used topically for conditions like head lice and rosacea. The effectiveness and safety of Ivermectin for these approved indications are supported by extensive scientific evidence and regulatory approvals.

Regarding the claims about Ivermectin's efficacy against COVID-19, major health organizations, including the FDA, CDC, and WHO, have stated that there is no reliable scientific evidence to support its use for preventing or treating the virus. Clinical trials have not demonstrated significant benefits, and the FDA strongly advises against using Ivermectin for COVID-19, especially the animal formulations, which can be dangerous. It is essential to rely on scientifically validated treatments and public health guidance for managing infections like COVID-19.

At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to providing accurate information and high-quality pharmaceutical ingredients. We understand the importance of adhering to established scientific consensus and regulatory guidelines. Our focus is on supplying Ivermectin for its approved and well-researched applications, supporting healthcare professionals and researchers who rely on the purity and quality of our products.

Dispelling misinformation is vital for maintaining public trust in medical science and ensuring patient safety. We encourage individuals to consult healthcare professionals for accurate medical advice and to rely on credible sources of information regarding pharmaceutical treatments. NINGBO INNO PHARMCHEM CO.,LTD. continues to champion the responsible use of Ivermectin, supporting its critical role in treating parasitic diseases and contributing to ongoing research in its other potential therapeutic areas.